Your browser doesn't support javascript.
loading
Research advances on bifidobacterium and inflammatory bowel disease / 中华全科医师杂志
Chinese Journal of General Practitioners ; (6): 731-734, 2018.
Article in Chinese | WPRIM | ID: wpr-710856
ABSTRACT
Inflammatory bowel disease (IBD) is achronic and relapsing inflammation of the intestinal tract.The pathogenesis of IBD is still unknown.In recent years,the research on the relationship between intestinal flora and IBD has become a hot topic.The change of intestinal flora may be one of the important pathogenic factors of IBD.Bifidobacterium is known as one of the probiotics in the intestine,the change of the bifidobacterium flora is closely related to the pathogenesis of IBD.It can effectively reduce the intestinal inflammatory response of IBD patients by enhancing the mucosal barrier function,regulating intestinal immunity and intestinal flora.The regulation of bifidobacterium in the intestine may have a positive effect on the treatment of IBD.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of General Practitioners Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of General Practitioners Year: 2018 Type: Article